Polynitrogen Bicyclic and Tricyclic Compounds as PDE4 Inhibitors
We report here two new series of designed PDE4 inhibitors, the first one showing the quinoline scaffold recently investigated by us through a fragment-based drug design strategy, and the second consisting of pyrazolo [1′,5′:1,6]pyrimido[4,5-<i>d</i>]pyridazine derivatives. Both the new s...
Saved in:
| Main Authors: | Claudia Vergelli, Agostino Cilibrizzi, Gabriella Guerrini, Fabrizio Melani, Marta Menicatti, Gianluca Bartolucci, Maria Paola Giovannoni, Letizia Crocetti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-08-01
|
| Series: | Applied Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3417/15/15/8678 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders
by: Min Kyu Park, et al.
Published: (2025-01-01) -
Recent progress in the synthesis of imidazoquinoline derivatives
by: Warda Jahangir, et al.
Published: (2025-05-01) -
The Effect of the <i>N</i>-Oxide Oxygen Atom on the Crystalline and Photophysical Properties of [1,2,5]Oxadiazolo[3,4-<i>d</i>]pyridazines
by: Timofey N. Chmovzh, et al.
Published: (2025-05-01) -
The multifaceted role of phosphodiesterase 4 in tumor: from tumorigenesis to immunotherapy
by: Huili-li Ren, et al.
Published: (2025-03-01) -
Efficacy and safety of PDE5 inhibitors in middle-aged and old patients with and without hypogonadism
by: Chunlin Wang, et al.
Published: (2024-12-01)